{"id":"gw685698x","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Tremor"}]},"_chembl":{"chemblId":"CHEMBL1676","moleculeType":"Small molecule","molecularWeight":"538.58"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PDE4 inhibition leads to accumulation of cyclic adenosine monophosphate (cAMP) in immune and inflammatory cells, suppressing the release of pro-inflammatory cytokines and chemokines. This mechanism reduces airway inflammation and mucus production, making it potentially useful in chronic inflammatory airway diseases. The selective PDE4 inhibition aims to provide anti-inflammatory benefits while minimizing systemic side effects associated with non-selective phosphodiesterase inhibition.","oneSentence":"GW685698X is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:47:35.662Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD)"},{"name":"Asthma"}]},"trialDetails":[{"nctId":"NCT00363740","phase":"PHASE3","title":"Study of GW685698X In Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-02-19","conditions":"Rhinitis, Allergic, Seasonal","enrollment":38},{"nctId":"NCT00603382","phase":"PHASE2","title":"A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-12-01","conditions":"Asthma","enrollment":599},{"nctId":"NCT00289198","phase":"PHASE3","title":"Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-02-07","conditions":"Rhinitis, Allergic, Perennial","enrollment":301},{"nctId":"NCT00117325","phase":"PHASE3","title":"Study Of Adults And Adolescents With Vasomotor Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-07-11","conditions":"Rhinitis, Vasomotor","enrollment":352},{"nctId":"NCT00398645","phase":"PHASE2","title":"A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11-15","conditions":"Asthma","enrollment":648},{"nctId":"NCT00419237","phase":"PHASE1","title":"Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01-13","conditions":"Asthma","enrollment":20},{"nctId":"NCT00603746","phase":"PHASE2","title":"A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-12-01","conditions":"Asthma","enrollment":627},{"nctId":"NCT00118703","phase":"PHASE3","title":"Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-07-01","conditions":"Vasomotor Rhinitis, Rhinitis, Vasomotor","enrollment":350},{"nctId":"NCT00625196","phase":"PHASE1","title":"Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02-27","conditions":"Asthma","enrollment":16},{"nctId":"NCT00538057","phase":"PHASE1","title":"Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-10-02","conditions":"Asthma","enrollment":16},{"nctId":"NCT00444509","phase":"PHASE1","title":"Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-02-17","conditions":"Asthma","enrollment":20},{"nctId":"NCT00522678","phase":"PHASE1","title":"Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-02-15","conditions":"Asthma","enrollment":36},{"nctId":"NCT00972673","phase":"PHASE1","title":"A Study of GW685698X in Healthy Japanese Male Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-09-24","conditions":"Asthma","enrollment":48},{"nctId":"NCT00197262","phase":"PHASE3","title":"Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-08","conditions":"Rhinitis, Allergic, Seasonal","enrollment":288},{"nctId":"NCT00108914","phase":"PHASE3","title":"Perennial Allergic Rhinitis Study In Pediatric Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-02","conditions":"Rhinitis, Allergic, Perennial","enrollment":558},{"nctId":"NCT01630135","phase":"PHASE3","title":"Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-06","conditions":"Rhinitis, Allergic, Perennial","enrollment":261},{"nctId":"NCT01622231","phase":"PHASE3","title":"Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-06","conditions":"Rhinitis","enrollment":61},{"nctId":"NCT00603278","phase":"PHASE2","title":"A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-12","conditions":"Asthma","enrollment":622},{"nctId":"NCT00539006","phase":"PHASE4","title":"Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":377},{"nctId":"NCT00519636","phase":"PHASE4","title":"Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":360},{"nctId":"NCT00766090","phase":"PHASE2","title":"Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-10","conditions":"Asthma","enrollment":190},{"nctId":"NCT00224523","phase":"PHASE3","title":"Long Term Safety Of GW685698X Via Nasal Biopsy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09","conditions":"Rhinitis, Allergic, Perennial","enrollment":125},{"nctId":"NCT00103454","phase":"PHASE3","title":"A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":288},{"nctId":"NCT00225823","phase":"PHASE3","title":"Study In Adults And Adolescents With Seasonal Allergic Rhinitis.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-05","conditions":"Rhinitis, Allergic, Seasonal","enrollment":288},{"nctId":"NCT00116883","phase":"PHASE3","title":"A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-02","conditions":"Rhinitis, Allergic, Perennial","enrollment":90},{"nctId":"NCT00118729","phase":"PHASE3","title":"Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-04","conditions":"Rhinitis, Allergic, Seasonal","enrollment":380},{"nctId":"NCT00107757","phase":"PHASE3","title":"Seasonal Allergic Rhinitis In Pediatric Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-03","conditions":"Rhinitis, Allergic, Perennial","enrollment":576},{"nctId":"NCT01499446","phase":"PHASE2","title":"A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-09","conditions":"Asthma","enrollment":669},{"nctId":"NCT00109486","phase":"PHASE3","title":"Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-04","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":56},{"nctId":"NCT00116818","phase":"PHASE3","title":"A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":90},{"nctId":"NCT00115622","phase":"PHASE3","title":"Study In Adults And Adolescents With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-12","conditions":"Hayfever, Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis","enrollment":304}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"GW685698X","genericName":"GW685698X","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GW685698X is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels. Used for Chronic obstructive pulmonary disease (COPD), Asthma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":8,"withResults":4},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}